Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

donepezil

donepezil
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Adlarity FILM, TRANSDERMAL 5 mg/day, 10 mg/day      
Aricept ODT TABLET, DISINTEGRATING, ORAL 5 mg, 10 mg    
Aricept TABLET, ORAL 5 mg, 10 mg      
Aricept TABLET, ORAL 23 mg    
VIEW MORE Parasympathomimetic (Cholinergic) Agents
CLASS
120400
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

Notes

donepezil (Aricept)

  • 23 mg tablet oral ONCE Daily

 

donepezil (Aricept)

  • TWO 10 mg tablets oral ONCE Daily (Total: 20 mg)
  

donepezil (Aricept ODT)

  • 5 mg disintegrating tablet oral
  • 10 mg disintegrating tablet oral

donepezil (Aricept)

  • 5 mg tablet oral
  • 10 mg tablet oral

 Donepezil regular tablets may be crushed for patients unable to swallow tablets

Adlarity - Inpatients may use home supply.

Reviewed: October 26, 2010 (Aricept 23), July 2023 (Adlarity)

Spotlight Donepezil transdermal patch (Adlarity)

Last updated: Aug. 28, 2023






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved